Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 17;135(4):e188182.
doi: 10.1172/JCI188182.

Long COVID is associated with lower percentages of mature, cytotoxic NK cell phenotypes

Long COVID is associated with lower percentages of mature, cytotoxic NK cell phenotypes

Tasha Tsao et al. J Clin Invest. .
No abstract available

Keywords: Immunology; Infectious disease; Innate immunity; NK cells.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors have declared that no conflict of interest exists.

Figures

Figure 1
Figure 1. Relationships between NK cell phenotypes and long COVID.
(AG) Age (A), the percentage of male and female participants (B), the number of symptoms (sx) during acute infection (C), mean SARS-CoV-2 total anti-receptor binding domain (RBD) IgG levels (D), along with percentages of total CD56+ NK cells (E), CD56dim/CD16+ NK cells (F), and CD56dim NK cells expressing KIR2D (L1/S1/S3/S5) (G) approximately 4 months following acute infection in those with long COVID (LC) and those who fully recovered. (H and I) Spearman’s correlation analysis of CD56dim/CD16+ NK cell percentages and the number of LC symptoms (H), and the percentage of CD56dim/CD16+ NK cells in participants with neurocognitive (neuro), gastrointestinal (GI), fatigue, and cardiopulmonary (CP) LC (I) are shown. (J and K) CD56dim/CD16+ NK cell percentages in male and female participants (J) and repeat CD56dim/CD16+ comparisons, including only female participants (K). (L and M) NK cell cluster UMAP (L) and the percentage of adaptive NK cell clusters by LC symptom group, CMV IgG serostatus, and presence or absence of SARS-CoV-2 spike or nucleocapsid antigen in blood after COVID-19 (M). Mean (bars) and 95% confidence intervals are shown. P values are from 2-tailed Mann-Whitney U testing (I, J, and M) or Kruskal-Wallis testing (C, F, G, and K).

References

    1. Yin K, et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024;25(2):218–225. doi: 10.1038/s41590-023-01724-6. - DOI - PMC - PubMed
    1. Maucourant C, et al. Natural killer cell immunotypes related to COVID-19 disease severity. Sci Immunol. 2020;5(50):eabd6832. doi: 10.1126/sciimmunol.abd6832. - DOI - PMC - PubMed
    1. Varchetta S, et al. Unique immunological profile in patients with COVID-19. Cell Mol Immunol. 2021;18(3):604–612. doi: 10.1038/s41423-020-00557-9. - DOI - PMC - PubMed
    1. Peluso MJ, et al. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement. Open Forum Infect Dis. 2021;9(2):ofab640. doi: 10.1093/ofid/ofab640. - DOI - PMC - PubMed